Cargando…

Identification of FLT3 and NPM1 Mutations in Patients with Acute Myeloid Leukaemia

OBJECTIVE: The most frequent acquired molecular abnormalities and important prognostic indicators in patients with Acute Myeloid Leukaemia (AML) are fms-like tyrosine kinase-3 gene (FLT3) and nucleophosmin-1 (NPM1) mutations. Our study aims to develop a cost effective and comprehensive in-house conv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yusoff, Yuslina Mat, Seman, Zahidah Abu, Othman, Norodiyah, Kamaluddin, Nor Rizan, Esa, Ezalia, Zulkiply, Nor Amalina, Abdullah, Julia, Zakaria, Zubaidah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7021611/ https://www.ncbi.nlm.nih.gov/pubmed/31244296 http://dx.doi.org/10.31557/APJCP.2019.20.6.1749

Ejemplares similares

Prevalence of BCR-ABL T315I Mutation in Malaysian Patients with Imatinib-Resistant Chronic Myeloid Leukemia
por: Yusoff, Yuslina Mat, et al.
Publicado: (2018)

Comprehensive analysis of mutations and clonal evolution patterns in a cohort of patients with cytogenetically normal acute myeloid leukemia
por: Mat Yusoff, Yuslina, et al.
Publicado: (2021)

Whole-Exome Sequencing of ETV6/RUNX1 in Four Childhood Acute Lymphoblastic Leukaemia Cases
por: Zakaria, Zubaidah, et al.
Publicado: (2017)

Circulating cytokines and small molecules follow distinct expression patterns in acute myeloid leukaemia
por: Islam, Mirazul, et al.
Publicado: (2017)

Chromosomal Aberrations in ETV6/RUNX1-positive Childhood Acute Lymphoblastic Leukemia using 244K Oligonucleotide Array Comparative Genomic Hybridization
por: Zakaria, Zubaidah, et al.
Publicado: (2012)

Systematic review and meta-analysis of mesenchymal stromal/stem cells as strategical means for the treatment of COVID-19
por: Taufiq, Hannah, et al.
Publicado: (2023)

Clinico-Haematologic association and prognostic relevance of NPM1 and FLT3-ITD mutations in acute Myeloid Leukaemia
por: Mahmood, Rafia, et al.
Publicado: (2019)

FLT3‐targeted therapy restores GATA1 pathway function in NPM1/FLT3‐ITD mutated acute myeloid leukaemia
por: Sorcini, D, et al.
Publicado: (2023)

Gene expression profiling and in vitro functional studies reveal RAD54L as a potential therapeutic target in multiple myeloma
por: Bong, Ivyna Pau Ni, et al.
Publicado: (2022)

Characterization of New Alpha Zero (α(0)) Thalassaemia Deletion (−−(GB)) among Malays in Malaysian Population
por: Yasin, Norafiza Mohd, et al.
Publicado: (2023)

A blood-based gene expression and signaling pathway analysis to differentiate between high and low grade gliomas
por: Ponnampalam, Stephen N., et al.
Publicado: (2017)

The value of molecular stratification for CEBPA (DM) and NPM1 (MUT) FLT3 (WT) genotypes in older patients with acute myeloid leukaemia
por: Dickson, Glenda J., et al.
Publicado: (2015)

Prognostic Relevance of NPM1 and FLT3 Mutations in Acute Myeloid Leukaemia, Longterm Follow-Up—A Single Center Experience
por: Borlenghi, Erika, et al.
Publicado: (2022)

Molecular characterisation of NPM1 and FLT3-ITD mutations in a central South African adult de novo acute myeloid leukaemia cohort
por: Kloppers, Jean F., et al.
Publicado: (2021)

NPM1 and FLT3-ITD/TKD Gene Mutations in Acute Myeloid Leukemia
por: Naseem, Shano, et al.
Publicado: (2021)

Hsa-miR-181a-5p, hsa-miR-182-5p, and hsa-miR-26a-5p as potential biomarkers for BCR-ABL1 among adult chronic myeloid leukemia treated with tyrosine kinase inhibitors at the molecular response
por: Mohd Yacob, Aliza, et al.
Publicado: (2022)

New Quantitative Method to Identify NPM1 Mutations in Acute Myeloid Leukaemia
por: Huet, Sarah, et al.
Publicado: (2013)

Preferential transcription of the mutated allele in NPM1 mutated acute myeloid leukaemia
por: Bailey, G. D., et al.
Publicado: (2020)

Targeting and Monitoring Acute Myeloid Leukaemia with Nucleophosmin-1 (NPM1) Mutation
por: Chin, Lynn, et al.
Publicado: (2023)

MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status
por: Faraoni, Isabella, et al.
Publicado: (2012)

Molecular and hematological studies in a cohort of beta zero South East Asia deletion (β°-thal SEA) from Malaysian perspective
por: Yasin, Norafiza Mohd, et al.
Publicado: (2022)

Cup‐like blasts in acute myeloid leukaemia with NPM1 and IDH2 mutations
por: Ohya, Eiko, et al.
Publicado: (2021)

Mutation of NPM1 and FLT3 Genes in Acute Myeloid Leukemia and Their Association with Clinical and Immunophenotypic Features
por: Chauhan, Pradeep Singh, et al.
Publicado: (2013)

A novel NPM1-RARG-NPM1 chimeric fusion in acute myeloid leukaemia resembling acute promyelocytic leukaemia but resistant to all-trans retinoic acid and arsenic trioxide
por: Chen, Xue, et al.
Publicado: (2019)

Effectiveness of imatinib mesylate over etoposide in the treatment of sensitive and resistant chronic myeloid leukaemia cells in vitro
por: Husaini, Roslina, et al.
Publicado: (2017)

Combination strategies to overcome drug resistance in FLT(+) acute myeloid leukaemia
por: Yang, Jingmei, et al.
Publicado: (2023)

Clinical relevance of mutant NPM1 and CEBPA in patients with acute myeloid leukaemia – preliminary report
por: Helbig, Grzegorz, et al.
Publicado: (2014)

Examination of the FLT3 and NPM1 mutational status in patients with acute myeloid leukemia from southeastern Poland
por: Koczkodaj, Dorota, et al.
Publicado: (2016)

DNA damage corrects the aberrant cytoplasmic localisation of nucleophosmin in NPM1 mutated acute myeloid leukaemia
por: Bailey, Graham D., et al.
Publicado: (2019)

Prognostic Relevance of DNMT3A, FLT3 and NPM1 Mutations in Syrian Acute Myeloid Leukemia Patients
por: Moualla, Yahia, et al.
Publicado: (2022)

Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia
por: Park, Jung Eun, et al.
Publicado: (2013)

Clinical features of De Novo acute myeloid leukemia with concurrent DNMT3A, FLT3 and NPM1 mutations
por: Loghavi, Sanam, et al.
Publicado: (2014)

The prognostic impact of FLT3-ITD and NPM1 mutations in patients with relapsed acute myeloid leukemia and intermediate-risk cytogenetics
por: How, J, et al.
Publicado: (2013)

Outcomes of Older Patients with NPM1 Mutated and FLT3-ITD Negative Acute Myeloid Leukemia Receiving Allogeneic Transplantation
por: Jentzsch, Madlen, et al.
Publicado: (2020)

Minor BCR-ABL1-Positive Acute Myeloid Leukemia Associated With the NPM1 Mutation and FLT3 Internal Tandem Duplication
por: Kim, Moon Jung, et al.
Publicado: (2016)

Prognostication refinement in NPM1‐mutated acute myeloid leukemia stratified by FLT3‐ITD status with different induction doses of cytarabine
por: Wang, Biao, et al.
Publicado: (2023)

Flt3-ITD mutations in a mouse model of radiation-induced acute myeloid leukaemia
por: Finnon, R, et al.
Publicado: (2012)

FLT3‐ITD mutations in acute myeloid leukaemia – molecular characteristics, distribution and numerical variation
por: Engen, Caroline, et al.
Publicado: (2021)

Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia
por: Jensen, Christopher E., et al.
Publicado: (2022)

Computer simulations of the signalling network in FLT3 (+)-acute myeloid leukaemia – indications for an optimal dosage of inhibitors against FLT3 and CDK6
por: Buetti-Dinh, Antoine, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vqrc8deh7le471mnp4a12tof2d